Conference Programme


Overview

The ICoN 2013 conference will bring together clinicians, scientists and engineers, in uniquely interdisciplinary environment, to address the multi-faceted challenges of theranostics.

You can download the conference program here (PDF).




Programme at a glance


  International Conference on Nanotheranostics (ICoN 2013)
  Thursday
26/09/2013
Friday
27/09/2013
Saturday
28/09/2013
09:00 - 11:00

Welcome and
Plenary Session
Session 3

Biocompatibility and Toxicity of Nanotheranostic Agents
Short Course

Nanomedicine
11:00 - 11:30 Coffee Break
11:30 - 13:30 Session 1

Imaging and Characterization of Nanotheranostic Agents
Session 4

Drug Delivery to Solid Tumors and Through Barriers
Session 6

Cancer Theranostics
13:30 - 14:30 Lunch Break
14:30 - 16:45 Session 2

Novel Nanotheranostic Approaches
Session 5

Delivery of Nanotheranosis
Session 7

Materials and Tissues in Nanotheranostics
16:45 - 17:15 Coffee Break
17:15 - 18:30 Poster Session Cultural / Social Events Roundtable Discussion / Student Awards
 
20:00 - 23:00 Conference Dinner  

You can download the conference program here (PDF).




Sessions

Thursday 26/9/2013
Plenary Session
09.00 - 09.15 Welcome
Andreani Odysseos, Conference Chair, EPOS-Iasis R&D Ltd
09.15 - 09.30 Welcome by the Cyprus Medical Association
Dr. Andreas Demetriou, CyMA President
09.30 - 09.50 European Commission's Marie Curie Program in Horizon 2020
Dr. Audrey Arfi, European Commission Scientific Oficcer
09.50 - 10.00 Opening by the President of the House of Representatives
H.E. Mr. Yiannakis Omirou
10.00 - 10.45 Opportunities Offered by Nucleic Acid-Based Nano-Devices in Cancer Therapy and Theranostics
Jan Mollenhauer, Ines Block, Angela Riedel, Steffen Schmidt, Helle Christiansen, Birgitte Brinkmann Olsen, Helge Thisgaard, Poul Flemming Hoilund-Carlsen, Stefan Vogel and Jesper Wengel, University of Southern Denmark, Denmark
10.45 - 11.30 Nanoscale Interface Between Engineered Matter and Living Organisms: Understanding the Biological Identity of Nanosized Materials
Kenneth Dawson, UC Doublin, Ireland
11.30 - 11.45 Coffee Break
Session 1 - Imaging and Characterization of Nanotheranostic Agents
Session Chair: Pavlos Agianian, Democritus University of Thrace, Greece
11.45 - 12.35 Assessing biological specificity of nanoparticles in vitro: test tubes, chips or cells
Pavlos Agianian, Democritus University of Thrace, Greece
12.35 - 12.55 In-vitro release study and dynamic in-vivo imaging of pH- and Magnetic field sensitive hybrid microspheres
Eleni Efthimiadou, NCSR Demokritos, Greece
12.55 - 13.15 Preparation and characterization of new elements for the conception of nanohybrids for multicolored bioimaging
Morgane Rivoal and Andreani Odysseos, EPOS Iasis R&D Ltd, Cyprus
13.15 - 13.35 Size Dependent Biological Profiles of Pegylated Gold Nanorods for Biomedical Applications
Federica Scaletti, University of Florence, Italy
13.35 - 14.30 Lunch Break
Session 2 - Novel Nanotheranostic Approaches
Session Chair: Jean-Michel Siaugue, UPMC, France
14.30 - 15.20 Fluorescent and magnetic silica core shell nanoparticles for biomedical applications
Jean-Michel Siaugue, UPMC, France
15.20 - 15.40 Two different approaches for the synthesis of functionalized silica coated magnetic nanoparticles
Ana B. Davila Ibañez, Verónica Salgueiriño and Jean-Michel Siaugue, UPMC, France
15.40 - 16.00 Theragnosis combining ferrocenyl derivatives, carbohydrates and nanovectors
Jeremy Malinge, Jean-Michel Siaugue, Christine Ménager, Matthieu Sollogoub, Yongmin Zhang, Gérard Jaouen and Anne Vessières-Jaouen, UPMC, France
16.00 - 16.20 Chirosan – linear aldehyde nanoparticles obtained from reverse micellar method
Krzysztof Gawlik, Iga Wasiak and Tomasz Ciach, Warsaw University of Technology, Poland
16.20 - 17.00 New Routes Towards the Synthesis of Natural Products and Designed Derivatives
Elias Couladouros, Agricultural University of Athens, Greece
16.45 - 17.15 Coffee Break
Poster Session and Reception
Session Chair: Dr. Costas Pitris, University of Cyprus, Cyprus
1 Hemocompatibility of nanoparticles: impact on fibrinolysis
Valentine Minet, Jean-Michel Dogné, Bernard Chatelain, François Mullier and Julie Laloy, University of Namur, Belgium
2 Hemocompatibility of silver nanoparticles
Julie Laloy, Valentine Minet, Lutfiye Alpan, Bernard Chatelain, François Mullier and Jean-Michel Dogné, University of Namur, Belgium
3 From docking to synthesis and grafting: Preliminary results for new Anilinoquinazolines as potential EGFR inhibitors in multifunctional nanocarriers
Fotini Liepouri, Pavlos Agianian, Vassiliki Garefalaki, Elias Couladouros, Andreani Odysseos and Alexandros Strongilos, Proactina SA, Greece
4 Theoretical investigation of a new metal nanoparticle for combined imaging and therapy applications
Myria Angelidou and Costas Pitris, University of Cyprus, Cyprus
5 Surface Enhanced Raman Spectroscopy (SERS) for Point-Of-Care Diagnosis of Urinary Tract Infections
Katerina Hadjigeorgiou, Evdokia Kastanos and Costas Pitris, University of Cyprus, Cyprus
6 Activity, anti-cancer effect and nanodelivery of new anilinoquinazoline EGFR inhibitors
Eftychia Angelou, Fotini Liepouri, Maria Pavlaki, Andreani Odysseos, Jean-Michel Siaugue, Alexandros Strongilos and Pavlos Agianian. Democritus University of Thrace, Greece


Friday 27/9/2013

Session 3 - Biocompatibility and Toxicity of Nanotheranostic Agents
Session Chair: Cyrill Bussy, University of Manchester, UK
09.00 - 09.50 Toxicity and Safety of Carbon Nanomaterials for Biomedical Applications
Cyrill Bussy and Kostas Kostarelos, University of Manchester, UK
09.50 - 10.10 Guidelines proposal for studying hemocompatibility of manufactured nanoparticles
Julie Laloy, Lutfiye Alpan, Valentine Minet and Jean-Michel Dogné, University of Namur, Belgium
10.10 - 10.30 Hemocompatibility of Albumin microspheres as drug delivery system, in vitro study
Mohamed Elblbesy, University of Tabuk, Saudi Arabia
10.30 - 10.50 Rat whole-body exposure model to nanoaerosol: Development with silicon carbide nanoparticles and study of their toxicity
Julie Laloy, Omar Lozano, Lutfiye Alpan, Valentine Minet, Olivier Toussaint, Bernard Masereel, Jean-Michel Dogné and Stephane Lucas, University of Namur, Belgium
11.00 - 11.30 Coffee Break

Session 4 - Drug Delivery to Solid Tumors and Through Barriers
Session Chair: Triantafyllos Stylianopoulos, University of Cyprus, Cyprus
11.30 - 12.20 EPR-effect: a barrier to the effective delivery of large nanomedicines to solid tumors
Triantafyllos Stylianopoulos, University of Cyprus, Cyprus
12.20 - 12.40 Strategies to improve nanomedicine delivery to solid tumors
Konstantinos Soteriou, Eva-Athena Economides and Triantafyllos Stylianopoulos, University of Cyprus, Cyprus
12.40 - 13.00 Methods for delivery of living cells to the respiratory system via aerosol route
Tomasz R. Sosnowski and Ewelina Tomecka, Warsaw University of Technology, Poland
13.00 - 13.20 Enhancement of Drug Absorption Across Intestinal Membrane Using Magnetic Beads
Anjali Seth, David Lafargue and Christine Ménager, UPMC, France
13.30 - 14.30 Lunch Break

Session 5 - Delivery of Nanotheranosis
Session Chair: Mike Averkiou, University of Cyprus, Cyprus
14.30 - 15.20 Ultrasound and microbubbles for monitoring therapies targeting tumor vascularity
Mike Averkiou, University of Cyprus, Cyprus
15.20 - 15.40 Tunable magnetic/ICG small protocells as a platform for drug delivery
Jean-Sébastien Thomann, Gaëlle Corne, Didier Arl, Naoufal Bahlawane and Damien Lenoble, CRP Gabriel lippmann, Luxemburg
15.40 - 16.00 Ultrasound-induced temperature elevation for in-vitro controlled release of temperature-sensitive liposomes
Christophoros Mannaris, Jean-Michele Escoffre, Ayache Bouakaz, Marie-Edithe Meyre and Michalakis Averkiou, University of Cyprus, Cyprus
16.00 - 16.20 Biodegradable Dextran Nanoparticles as Potential Drug and Fluorescent Marker Carrier
Tomasz Ciach, Magdalena Janczewska and Iga Wasiak, Warsaw University of Technology, Poland
16.20 - 16.40 Engineering carbon nanotubes based scaffolds for the efficient delivery of new tyrosine kinase inhibitors
Davide Giust, Kostas Kostarelos, UCL School of Pharmacy, UK
16.45 - 17.15 Coffee Break

Cultural Activities and Conference Dinner
17.15 - 18.30
20.30 - 23.00
Visit to cultural heritage sites
Conference dinner


Saturday 28/9/2013

Session 6 - Cancer Theranostics
Session Chair: Costas Pitsillides, Cyprus University of Technology, Cyprus
09.00 - 09.50 Folic Acid functionalized Quatro-NanoContainers as targeted agent: In vitro and In vivo study
George Kordas, NCSR Demokritos
09.50 - 10.10 Doxorubicin-loaded and Antibody-Conjugated Liposome-QD Hybrid Vesicles for Targeted Cancer Theranostics
Bowen Tian, Wafa Al-Jamal, Bowen Tian and Kostas Kostarelos, University of Manchester, UK
10.10 - 10.30 Monitoring tumor burden by multicolor in vivo flow cytometry
Costas Pitsillides, Konstantinos Kapnisis and Andreas Anayiotos, Cyprus University of Technology, Cyprus
10.30 - 10.50 Role of the Cell-Division Cycle on Nanoparticle Cellular Accumulation and Implications for Cancer Targeting
Christoffer Åberg and Kenneth A. Dawson, UC Doublin, Ireland
11.00 - 11.30 Coffee Break

Short Course: Nanotheranostics: all-in-one personalized medicine
This short course will provide an overview of the major concepts behind the newly created field of nanotheranostics. Nanotheranostic agents have a number of significant advantages over current approaches: (i) Nanotheranostic agents can be customized to the disease and personalized to the patient. (ii) Active targeting and localization allows for better treatment with much less intense side effects compared to current regimens. (iii) The integration of therapy and monitoring provides real-time information on whether or not the specific treatment regimen is working for the specific patient. Given these attributes, it is not surprising that the field of nanotheranostics is considered the future of treatment of highly inhomogeneous and variable diseases such as cancer and chronic inflammatory disorders.
11.30 - 11.45 Introduction
Going to the lower limits: nanotechnology and nanomedicine
Theranostics: all-in-one personalized medicine
Andreani Odysseos, EFB, EPOS-Iasis R&D Ltd, Cyprus
11.45 - 12.05 Theranostic Nanoparticles
Rena Bizios, University of Texas at San Antonio, USA
12.05 - 12.25 Clinical applicability of Optical Imaging
Costas Pitris, University of Cyprus, Cyprus
12.25 - 12.45 Nanotheranostics at the clinical fore
Image-guided therapy: paving the way of nanotheranostic agents to the clinic
Monitoring therapy by imaging
Andreani Odysseos, EFB, EPOS-Iasis R&D Ltd, Cyprus
12.45 - 13.00 Image-guided quantification of drug delivery: a revolution in Radiology (Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI))
Radiation-based therapies
Costas Pitris, University of Cyprus, Cyprus
13.00 - 13.30 Discussion of Clinical Challenges and Prospects
13.30 - 14.30 Lunch Break

Session 7 - Materials and Tissues in Nanotheranostics
Session Chair: Theodora Krasia-Christoforou, University of Cyprus
14.30 - 15.20 Challenges in Nanotheranostics: A Materials Perspective
Rena Bizios, University of Texas at San Antonio, USA
15.20 - 15.40 Magnetoactive electrospun nanocomposite membranes in drug delivery and hyperthermia applications
Ioanna Savva, Andreani Odysseos, Loucas Evaggelou, Oana Marinica, Eugeniu Vasile, Ladislau Vekas, Yiannis Sarigiannis and Theodora Krasia-Christoforou, University of Cyprus, Cyprus
15.40 - 16.00 Electrospun PEO/PLLA Fibrous Meshes for Sustained Tyrosine Kinase Inhibitors Delivery in Situ
Maria Kokonou, Fotios Mpekris, Triantafyllos Stylianopoulos, Jean-Michel Siaugue and Andreani Odysseos, University of Cyprus, Cyprus
16.00 - 16.20 Drug delivery through reconstructed bronchial mucus modified by functional carrier particles (FCPs)
Marcin Odziomek, Tomasz Sosnowski and Leon Gradoń, Warsaw University of Technology, Poland
16.20 - 16.40 Agglomeration of Theophylline Nanoparticles: a New Protocol for Pulmonary Drugs Administration
EHeba Salem, Mohamed Abdelrahim, Kamal Abo Eid and Mohamed Sharaf, The University of Beni Suef, Egypt
16.45 - 17.15 Coffee Break

Round Table Discussion and Student Awards
Session Chair: Andreani Odysseos, EPOS-Iasis R&D Ltd, Cyprus
17.15 - 18.15 Round Table Discussion: Challenges and Opportunities in Nanotheranostics
Moderator: Andreani Odysseos
Panel Members: K. Dawson, J. Mollenhauer, H. Doumanides, K. Kostarellos
18.15 - 18.30 Best Student Paper Award

Click here to download the conference/sessions program (PDF).